This inventor holds 3 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Yujun Zhang: Innovator in Chemokine Research
Introduction
Yujun Zhang is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of chemokine research, holding a total of 3 patents. His work focuses on developing mutant chemokines that have potential therapeutic applications.
Latest Patents
Yujun Zhang's latest patents include innovations related to chemokine N-terminal deletion mutations. These inventions pertain to mutant chemokines and pharmaceutical compositions that inhibit the corresponding endogenous chemokine from binding or activating a responsive receptor. The claimed mutant chemokines can be administered to patients for the treatment or prophylaxis of chemokine-mediated diseases. Additionally, the inventions relate to isolated DNAs encoding the mutant chemokines, vectors, and recombinant host cells containing the same.
Career Highlights
Yujun Zhang is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in the field of chemokines. His work has the potential to impact the treatment of various diseases, showcasing his dedication to scientific innovation.
Collaborations
Yujun Zhang collaborates with notable colleagues, including Barrett J Rollins, to further enhance the scope and impact of his research.
Conclusion
Yujun Zhang's contributions to chemokine research exemplify the importance of innovation in the medical field. His patents and ongoing work at the Dana-Farber Cancer Institute Inc. highlight his commitment to developing new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile